porcin
epidem
diarrhea
viru
pedv
caus
vomit
diarrhea
dehydr
mortal
rate
newborn
pig
viru
highli
contagi
affect
pig
age
breed
pedv
report
mani
countri
sinc
first
identifi
britain
belgium
china
pedv
preval
porcin
rotaviru
transmiss
gastroenter
viru
also
caus
viral
diarrhea
pig
common
practic
prevent
pedv
infect
transfer
passiv
immun
sow
nurs
piglet
pregnant
sow
vaccin
inactiv
attenu
vaccin
antibodi
passiv
transfer
colostrum
transfer
pedv
immun
affect
length
time
piglet
suckl
antibodi
titer
sow
colostrum
inactiv
vaccin
rel
expens
ineffici
induc
mucos
immun
respons
given
preval
pedv
infect
novel
prevent
measur
urgent
need
pedv
member
genu
alphacoronaviru
famili
coronavirida
order
nidoviral
pleomorph
envelop
viru
contain
positivestrand
rna
genom
approxim
kb
length
cap
polyadenyl
tail
viru
contain
four
structur
protein
spike
integr
membran
envelop
e
nucleocapsid
n
protein
type
membran
glycoprotein
requir
viru
entri
host
cell
bind
viral
receptor
porcin
amino
peptidas
two
domain
protein
amino
acid
aa
last
aa
previou
work
shown
neutral
epitop
mainli
locat
antigen
variat
protein
especi
domain
make
prevent
pedv
infect
difficult
howev
base
surfac
express
function
protein
attract
target
genet
engin
pedv
vaccin
poxviru
use
platform
vaccin
develop
human
anim
swinepox
viru
spv
natur
mild
viru
potenti
function
vaccin
vehicl
follow
reason
spv
would
interf
matern
antibodi
b
spv
hostspecif
transmiss
speci
spv
express
foreign
gene
effect
modifi
includ
larg
amount
recombin
dna
moreov
low
deliveri
cost
use
platform
live
vaccin
advantag
spv
suggest
could
viabl
platform
develop
safe
live
vaccin
pedv
aim
studi
construct
recombin
spv
vaccin
express
truncat
protein
pedv
focu
protect
efficaci
pig
vero
cell
atcc
porcin
kidney
cell
atcc
purchas
american
type
cultur
collect
wildtyp
wt
spv
titer
plaqueform
unit
pfu
ml
determin
cell
isol
laboratori
two
strain
pedv
classic
strain
novel
strain
genbank
also
isol
character
laboratori
titer
isol
determin
plaqu
assay
vero
cell
portion
gene
pedv
encod
aa
nterminu
protein
insert
vector
briefli
pedv
st
gene
bp
amplifi
viru
genom
use
follow
two
primer
result
pcr
product
insert
plasmid
construct
fig
method
use
gener
recombin
spv
express
st
rspvst
green
fluoresc
protein
gfp
describ
previous
briefli
subconflu
cultur
cell
infect
wtspv
multipl
infect
moi
h
cell
transfect
plasmid
use
transfect
reagent
vazym
biotech
co
ltd
cell
harvest
h
lyse
five
round
freez
thaw
lysat
use
infect
cell
plate
plaqu
purif
recombin
viru
fluoresc
microscopi
zeiss
germani
briefli
ml
medium
contain
lmp
agaros
dingguo
beij
china
ad
well
plate
infect
cell
incub
day
plaqu
becam
visibl
fluoresc
microscop
plaqu
pick
resuspend
ml
medium
contain
fb
plaqu
purif
repeat
round
plaqu
given
well
show
green
fluoresc
insert
st
gene
express
st
protein
confirm
pcr
indirect
immunofluoresc
assay
ifa
respect
dna
isol
cell
infect
rspvst
extract
use
sdsproteas
kphenol
method
genom
dna
cell
infect
wtspv
use
neg
control
amplif
perform
dna
polymeras
vazym
biotech
jiangsu
china
use
follow
primer
expect
pcr
product
approxim
bp
long
analyz
growth
characterist
rspvst
viru
vitro
cell
grow
plate
infect
wtspv
rspvst
moi
supernat
infect
cell
harvest
h
postinfect
viral
titer
supernat
sampl
determin
plaqu
assay
ifa
perform
describ
previous
cell
grown
plate
infect
wtspv
rspvst
plaqueform
unit
pfu
ml
per
well
pbstreat
cell
use
neg
control
h
postinfect
cell
wash
three
time
pb
pbst
fix
cold
methanol
min
cell
wash
three
time
pbst
block
pbst
bovin
serum
albumin
bsa
follow
incub
h
antiserum
rais
pedv
strain
pbst
bsa
three
wash
pbst
cell
incub
rhodamineconjug
protein
boshid
wuhan
china
min
final
wash
pb
cell
examin
wbyith
fluoresc
microscopi
zeiss
germani
cell
monolay
infect
wtspv
rspvst
moi
incub
h
lysat
approxim
cell
run
sdspolyacrylamid
gel
transfer
onto
pvdf
membran
membran
block
skim
milk
pbst
overnight
incub
swine
convalesc
serum
contain
antibodi
pedv
strain
dilut
h
wash
three
time
pbst
membran
wash
incub
horseradish
peroxidas
hrp
conjug
antiswin
antibodi
wash
pbst
protein
band
develop
ecl
western
blot
substrat
biorad
usa
imag
use
alpha
innotech
fluor
chem
imag
r
system
minneapoli
mn
experiment
protocol
involv
pig
approv
laboratori
anim
monitor
committe
jiangsu
provinc
experiment
anim
neg
spv
pedv
antibodi
elisa
fifteen
onemonthold
pig
larg
white
randomli
divid
five
group
per
group
immun
twice
day
rspvst
pfu
ml
pb
protein
concentr
mgml
inactiv
pedv
strain
pfu
ml
pb
protein
concentr
mgml
inactiv
pedv
strain
pfu
ml
pb
protein
concentr
mgml
wtspv
pfu
ml
pb
protein
concentr
mgml
pb
alon
neg
control
protein
concentr
determin
use
nanodrop
spectrophotomet
live
vaccin
neg
control
administ
subcutan
oral
volum
ratio
inactiv
vaccin
mix
freund
incomplet
adjuv
administ
intramuscularli
sera
collect
anim
day
postprimari
immun
antibodi
titrat
passiv
transfer
studi
test
protect
efficaci
rspvst
vaccin
sera
collect
group
day
postimmun
pool
use
feed
onedayold
piglet
briefli
onedayold
piglet
verifi
pedv
neg
randomli
divid
five
group
per
group
fed
sera
vaccin
control
group
sera
ad
milk
ratio
ml
serum
per
liter
milk
piglet
fed
ml
serummilk
mixtur
five
time
per
day
second
day
serum
feed
five
piglet
randomli
select
group
infect
pedv
pfu
ml
pb
oral
via
gastric
tube
remain
five
piglet
group
infect
pedv
pfu
ml
pb
oral
via
gastric
tube
anim
monitor
day
clinic
sign
smallintestin
tissu
sampl
collect
anim
die
viru
challeng
histolog
day
postchalleng
surviv
anim
euthan
intramuscular
inject
combin
ketamin
mgkg
xylazin
mgkg
follow
intraven
inject
pentobarbit
sodium
overdos
mgkg
intestin
tissu
sampl
collect
small
intestin
sampl
process
histolog
analysi
fecal
sampl
collect
pig
daili
fece
use
homogen
pb
wv
frozen
thaw
three
time
vortex
centrifug
rpm
min
supernat
remov
centrifug
rpm
min
final
supernat
sampl
use
viru
titrat
pedv
infect
confirm
pedvmgenebas
revers
transcript
polymeras
chain
reaction
rtpcr
antibodi
titer
sera
immun
pig
measur
elisa
briefli
purifi
pedv
ad
plate
incub
overnight
plate
wash
three
time
pbst
block
skim
milk
pbst
h
serum
sampl
serial
dilut
incub
h
incub
plate
wash
three
time
pbst
hrpconjug
goat
antispa
igg
goat
antiporcin
iga
dilut
pbst
ad
well
plate
incub
room
temperatur
dark
min
wash
three
time
pbst
tmb
microwel
peroxidas
substrat
system
tiangen
ad
color
develop
incub
min
reaction
stop
sulfur
acid
assay
run
duplic
well
micropl
reader
biorad
use
measur
absorb
nm
assay
carri
describ
previous
cellular
immun
respons
assess
indirectli
measur
level
peripher
blood
lymphocyt
blood
collect
day
primari
immun
wtspv
rspvst
pb
blood
lymphocyt
isol
count
dilut
densiti
cell
aliquot
plate
dmem
contain
pedv
ad
well
incub
h
supernat
test
use
elisa
kit
excel
bio
china
accord
manufactur
instruct
standard
curv
gener
use
control
ifn
serial
dilut
pb
coat
onto
elisa
plate
overnight
level
serum
calcul
accord
standard
curv
microneutr
assay
perform
describ
previous
sera
collect
day
primari
immun
pig
immun
inactiv
inactiv
wtspv
rspvst
pb
one
hundr
twofold
serial
dilut
serum
sampl
mix
equal
volum
pfu
pedv
incub
antibodyviru
mixtur
use
infect
vero
cell
plate
cell
overlaid
agar
cell
incub
three
day
atmospher
microneutr
titer
express
reciproc
highest
serum
dilut
inhibit
cytopath
effect
cpe
data
analyz
use
oneway
anova
threshold
signific
establish
p
engin
effect
live
pdev
vaccin
use
spv
vector
express
st
novel
pedv
strain
result
vaccin
refer
rspvst
insert
st
gene
confirm
pcr
amplifi
fragment
gene
fig
infecti
titer
rspvst
wtspv
approxim
pfuml
cell
infect
rspvst
show
green
fluoresc
observ
fluoresc
microscopi
shown
fig
express
st
protein
confirm
ifa
fig
addit
probe
convalesc
serum
pedvinfect
pig
band
consist
predict
size
st
protein
detect
western
blot
cell
infect
rspvst
wtspv
fig
taken
togeth
observ
indic
st
protein
effici
express
rspvst
addit
rspvst
exhibit
growth
characterist
similar
wtspv
fig
safeti
rspvst
vaccin
assess
pig
week
postimmun
five
day
postimmun
pig
receiv
wtspv
rspvst
pox
mark
approxim
cm
diamet
around
site
inject
day
postimmun
pox
mark
substanti
reduc
pig
recov
week
indic
abnorm
bodi
temperatur
appetit
vaccin
anim
result
demonstr
rspvst
wtspv
well
toler
pig
humor
immun
respons
vaccin
rspvst
assess
indirect
elisa
pig
receiv
two
vaccin
day
antibodi
respons
detect
earli
day
sspecif
immun
respons
increas
gradual
time
anim
immun
rspvst
fig
igg
titer
anim
vaccin
rspvst
significantli
higher
receiv
wtspv
pb
lower
inactiv
vaccin
group
p
n
iga
titer
rspvst
group
significantli
higher
anim
receiv
inactiv
vaccin
pb
control
fig
addit
neutral
antibodi
detect
rspvst
group
mean
titer
day
postvaccin
neutral
antibodi
titer
rspvst
group
lower
inactiv
group
higher
group
vaccin
fig
p
anim
per
time
point
examin
cellular
immun
respons
pig
vaccin
inactiv
inactiv
rspvst
wtspv
pb
day
postimmun
fig
concentr
rspvstvaccin
pig
highest
among
five
experiment
group
inactiv
vaccin
result
higher
concentr
wtspv
pb
one
common
practic
protect
piglet
pedv
infect
passiv
transfer
matern
antibodi
vaccin
sow
examin
protect
efficaci
antibodi
induc
rspvst
vaccin
piglet
fed
sera
anim
vaccin
rspvst
inactiv
inactiv
wtspv
pb
follow
day
anim
challeng
either
piglet
fed
sera
pig
vaccin
rspvst
inactiv
vaccin
inactiv
inactiv
fulli
protect
homolog
viru
challeng
anim
succumb
challeng
heterolog
viru
fig
b
tabl
expect
anim
fed
sera
pig
vaccin
wtspv
pb
exhibit
clinic
sign
includ
diarrhea
loss
appetit
reduc
weight
gain
increas
mental
instabl
anim
die
day
postchalleng
histolog
examin
reveal
lesion
intestin
tissu
piglet
homolog
challeng
group
howev
evid
histolog
chang
observ
tissu
anim
die
heterolog
viru
challeng
well
receiv
sera
wtspv
pb
vaccin
die
either
viru
challeng
chang
includ
degener
necrosi
intestin
microvilli
infiltr
inflammatori
cell
fig
tabl
taken
togeth
result
show
sera
rspvst
anim
provid
complet
protect
infect
pedv
strain
upon
passiv
transfer
amino
acid
sequenc
protein
two
virus
compar
sequenc
align
indic
amino
acid
sequenc
ident
two
strain
howev
protein
amino
acid
delet
posit
nterminu
within
neutral
epitop
three
consecut
amino
acid
differ
posit
also
seven
amino
acid
mutat
three
previous
predict
antigen
domain
fig
differ
sequenc
neutral
epitop
may
contribut
observ
differ
clinic
respons
vaccin
rspvst
engin
live
spv
vaccin
express
truncat
protein
rspvst
novel
pedv
strain
vaccin
induc
robust
immun
respons
antigen
pedv
pig
provid
full
protect
homolog
challeng
wt
result
suggest
rspvst
promis
live
vaccin
candid
pedv
report
epitop
conserv
among
variou
pedv
strain
howev
unclear
whether
differ
strain
pedv
induc
crossimmun
respons
pig
commerci
ped
vaccin
china
inactiv
vaccin
protect
efficaci
weaken
due
differ
viru
genotyp
use
vaccin
gener
furthermor
inactiv
vaccin
induc
effici
mucos
immun
respons
potenti
reason
mani
report
lack
efficaci
commerci
pedv
vaccin
protein
key
compon
coronavirus
contain
neutral
epitop
genet
variabl
increas
difficulti
gener
vaccin
pedv
result
indic
vaccin
inactiv
inactiv
result
effect
protect
homolog
viru
challeng
heterolog
viru
challeng
rspvst
express
truncat
protein
strain
provid
protect
classic
strain
indic
lack
crossprotect
result
may
also
provid
insight
commerci
vaccin
develop
classic
pedv
strain
longer
effect
china
due
emerg
novel
pedv
strain
although
spv
caus
mild
lesion
studi
reaction
around
inject
site
subsid
quickli
without
leav
scar
skin
pig
immun
reaction
experi
interest
immun
rspvst
result
highest
iga
antibodi
titer
cytokin
respons
among
five
experiment
group
igg
titer
lower
elicit
inactiv
howev
rspvst
vaccin
provid
effici
protect
newborn
pig
effect
provid
inactiv
vaccin
find
indic
neutral
antibodi
titer
criterion
whether
vaccin
effect
iga
antibodi
titer
cytokin
also
contribut
protect
result
show
efficaci
vaccin
evalu
measur
neutral
antibodi
titer
vitro
recent
year
poxviru
vector
vaccin
research
attract
widespread
attent
vaccinia
fowlpox
canarypox
virus
numer
potenti
applic
fpv
vector
use
commerci
poultri
vaccin
avian
influenza
viru
use
poxviru
vaccin
deliveri
vector
extens
explor
mammalian
avian
speci
spv
also
arous
interest
research
data
suggest
spv
live
vaccin
could
induc
sustain
humor
immun
respons
inact
vaccin
furthermor
live
spvbase
vaccin
induc
stronger
mucos
immun
respons
inactiv
vaccin
fail
induc
strong
mucos
immun
respons
elicit
lower
iga
antibodi
titer
compar
tradit
attenu
inactiv
vaccin
novel
spv
vector
vaccin
advantag
term
rout
immun
novel
spv
vector
vaccin
trigger
immun
respons
simpli
oral
administr
subcutan
pierc
without
immunoadjuv
save
effort
vaccin
also
result
less
stress
anim
thu
novel
spv
vaccin
show
promis
futur
applic
swine
industri
given
spv
pathogen
elicit
immun
respons
endem
spv
infect
may
repres
concern
vaccin
use
recombin
spv
address
problem
collect
random
serum
sampl
reserv
feeder
pig
determin
rate
spv
posit
agaros
gel
diffus
assay
data
shown
spv
posit
rate
approxim
report
spv
outbreak
recent
year
therefor
endem
spv
unlik
interfer
vaccin
program
use
rspv
vector
summari
describ
immunogen
protect
efficaci
recombin
spvbase
pedv
vaccin
express
truncat
protein
result
indic
inactiv
rspvst
vaccin
induc
complet
protect
passivetransf
piglet
model
upon
homologu
viru
challeng
fail
protect
heterolog
viru
challeng
expect
pedv
multival
vaccin
construct
use
spv
abl
prevent
homolog
heterolog
viral
infect
